Evidence map›Paper›PMID 41205049›Full record

ArticleDermatology and therapy2026

Patient and Caregiver Perceptions on Education and Treatment Needs in Atopic Dermatitis from an International Survey.

Kristen Willard, Špela Novak, Peter A Lio, Mark Luttmann, Gretchen McCreary, Ghulam Mustafa, Ruth Tal-Singer

Abstract read
In one paragraph

Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kristen WillardGlobal Allergy and Airways Patient Platform, Hendersonville, TN, USA.
Špela NovakGlobal Allergy and Airways Patient Platform, Hendersonville, TN, USA.
Peter A LioNorthwestern Feinberg School of Medicine, Chicago, IL, USA.
Mark LuttmannGlobal Allergy and Airways Patient Platform, Hendersonville, TN, USA.
Gretchen McCrearyGlobal Allergy and Airways Patient Platform, Hendersonville, TN, USA.
Ghulam MustafaCollege of Medicine, Shaqra University, Shaqra, Saudi Arabia.
Ruth Tal-SingerGlobal Allergy and Airways Patient Platform, Hendersonville, TN, USA. rtalsinger@gaapp.org.ORCID http://orcid.org/0000-0002-5275-8062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatient education initiatives for atopic dermatitis (AD) improve medication adherence, treatment satisfaction, severity of disease, and quality of life. An international survey was conducted to better understand the journey of diagnosis and treatment, unmet needs, and educational preferences of patients and caregivers for children diagnosed with AD residing in the US, Europe, Japan, and the Gulf region.

methodsA cross-sectional, anonymous, multilingual online survey was conducted from December 2024-January 2025. Eligible individuals were aged ≥ 18 years and either a patient diagnosed with AD by a medical professional or a caregiver for a child ages 6-12 years with AD.

resultsOf the 1103 survey participants (68% adult patients; 32% caregivers), 56% were from the US, 25% from Europe, 13% from the Gulf region, and 6% from Japan. Over half (61%) found it easy or very easy to find information on AD; however, responses indicated an interest in improved content of available AD education. Almost half (46%) indicated it would be beneficial to have a list of questions to take to their doctor's appointment, 42% wanted more information about AD triggers, and 40% wanted a way to communicate the impact of AD to their doctor. For new medications, participants wished to understand safety, mechanism of action, duration of treatment, and the possibility of freedom from symptoms.

conclusionPatient and caregiver education in AD is essential for improving disease management and often-compromised quality of life. While access to disease information was reasonably high, there is a clear opportunity to improve and refine AD education content and provide actionable, patient-centered tools.

Indexed as

Atopic dermatitisDiagnosisEczemaEducationSurveyTools

Identifiers

PMID41205049
PMCPMC12872953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.